There are many courses and books that one can consult to learn how to correctly design and analyse your study. It is equally important to know the "how not to" as well. A simple analogy is to look at the way we take instructions on the labels on our shirts before putting them to wash (e.g. do not machine wash, do not tumble dry, etc) if we want a shirt that looks nice and lasts longer!
INTRODUCTION
There are many courses and books that one can consult to learn how to correctly design and analyse your study. It is equally important to know the "how not to" as well. A simple analogy is to look at the way we take instructions on the labels on our shirts before putting them to wash (e.g. do not machine wash, do not tumble dry, etc) if we want a shirt that looks nice and lasts longer!
CHOOSING THE INAPPROPRIATE STUDY DESIGN
The study design contributes a large extent towards the scientific validity and quality of a research project. It is difficult to correct and fix an incorrectly designed study unless one can travel back in time! The choice of study design depends on a number of factors, including objectives of the study, prevalence of outcomes and risk factors and to a lesser extent available cost/logistics as well as timeline for project completion. In order to choose and apply the correct study design, one must understand the various designs and their associated features.
If the aim of the study was to establish the efficacy of a new drug compared to an existing drug, one could conduct a randomised controlled trial, particularly if there are concerns relating to confounding and minimising selection/interviewer/assessor bias. On the other hand, if the objective was to identify a causal link between smoking and Chronic Obstructive Pulmonary Disease (COPD), a cohort study may be particularly useful. However, if the outcome was rare (e.g. Buerger's disease), then a case-control design would be relatively more applicable.
Common mistakes include improper assessment of exposure (e.g. recall bias) in a case-control study, selecting cases and controls based on the exposure instead of outcome variable, using a cross-sectional study to establish causality, and comparing groups from across different randomised controlled trials. Even within a single particular study design, incorrect procedures can be employed (e.g. selecting cases and controls from two different populations).
SELECTING TOO FEW SUBJECTS IN THE STUDY
Recruiting larger than necessary subjects results in wastage in cost and resources, and may expose the additional people to risks inherent in the study. Conversely, when there are too few patients recruited, such studies may not adequately demonstrate a statistically significant result. These are typically known as under-powered studies. Typically 80% is used. Lower power implies a higher type 2 error (i.e. failure to reject the null hypothesis when it is actually false). Table 1 highlights an example of how sample size is related to the statistical significance of a study. If too few subjects are recruited (i.e. n=20), the possibility of type 2 error is high. Under-powered studies are common in the medical field. In a review of randomised controlled trials assessing clinical efficacy of treatments for adult rheumatic diseases, published in English, between 2001 and 2002, of the 86 negative or indeterminate trials, only 43 (50%) were found to have adequate sample size for a power of 80% (i.e. type 2 error of 20%) 1 . Power calculations are sometimes done retrospectively after a study is completed, often at the request of journal editors and reviewers whenever the power of the study is in doubt.
To avoid the problem of having under-powered studies, one needs to consult a biostatistician early in the design stage to help accurately calculate the number of subjects needed for the study before it is actually conducted. The statistician can also help with more complex designs (e.g. cluster randomised trials), and account for drop-outs and crossovers in the sample size calculations.
UNDERTAKING INCORRECT STATISTICAL TESTS
The type of statistical test one performs on the dataset depends primarily on the aim of the study, the available sample size, number of groups being compared, whether comparisons are done of the same person, the nature of the data and variables as well as the distribution the variables come from. When in doubt, the clinician can consult a good biostatistics book, although it is probably easier to walk across the road and talk to an experienced biostatistician! The use of incorrect statistical methods in medical journals is a problem that cannot be neglected, and increasingly many statisticians have been invited to be on the editorial review boards in many medical journals to address this problem.
It has been reported that 24% of studies reviewed, incorrectly used multiple t tests instead of the ANOVA, 5% treated repeated measurements as independent observations, and another 5% used the chi-squared test when the expected frequencies were too small 2 . There are many other examples not just in journals but in conference and other proceedings. In a recent conference, I observed a poster that presented mean values for two groups, but used the chi-squared test to incorrectly calculate the P value. I am pretty sure there are many other instances.
On a related note, ignoring the assumptions behind a statistical technique can also lead to incorrect results and conclusions. Figure 1a shows the Stata output from a hypothetical dataset, comparing the mean cholesterol between males and females. Results from the independent student t test seem to indicate that females have a significantly higher mean cholesterol level compared to males (P=0.0274). However, one of the main assumptions of the test (i.e. normality of data) was violated and ignored (data not shown), and a subsequent analysis using the Mann-Whitney test showed that indeed there was no significant difference between the two groups (Fig. 1b) .
In conclusion, it is probably unwise to ignore the dangers of incorrect design and analysis of a study. Partnership and effective communication between clinicians and biostatisticians are crucial in mitigating the errors resulting from such research and helping to improve the quality and quantity of good scientific medical research.
